Loading…
S-1 plus temozolomide as second-line treatment for neuroendocrine carcinoma of the breast: A case report
Saved in:
Published in: | World journal of clinical cases 2021-08, Vol.9 (24), p.7146-7153 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c343t-66a623e39c70c03231caf1e6174cf25fbe92a1c6c0dd12ce47bce2a2a727f7983 |
---|---|
cites | cdi_FETCH-LOGICAL-c343t-66a623e39c70c03231caf1e6174cf25fbe92a1c6c0dd12ce47bce2a2a727f7983 |
container_end_page | 7153 |
container_issue | 24 |
container_start_page | 7146 |
container_title | World journal of clinical cases |
container_volume | 9 |
creator | Wang, Xin Shi, Yan-Fen Duan, Jiang-Hui Wang, Chao Tan, Huang-Ying |
description | |
doi_str_mv | 10.12998/wjcc.v9.i24.7146 |
format | article |
fullrecord | <record><control><sourceid>pubmedcentral_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8409205</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>pubmedcentral_primary_oai_pubmedcentral_nih_gov_8409205</sourcerecordid><originalsourceid>FETCH-LOGICAL-c343t-66a623e39c70c03231caf1e6174cf25fbe92a1c6c0dd12ce47bce2a2a727f7983</originalsourceid><addsrcrecordid>eNpVkNtKw0AQhhdRbKl9AO_2BRL3kOxmvRBK8QQFL9TrZTOZ2JQkW3bTij69qRXRqxn4__kYPkIuOUu5MKa4et8ApHuTNiJLNc_UCZkKyXRSGMVO_-wTMo9xwxjjnOVcyXMykVmeMaP5lKyfE0637S7SATv_6VvfNRVSF2lE8H2VtE2PdAjohg77gdY-0B53wWNfeQiHEFyApvedo76mwxppObbjcE0XYxSRBtz6MFyQs9q1Eec_c0Ze725flg_J6un-cblYJSAzOSRKOSUkSgOaAZNCcnA1R8V1BrXI6xKNcBwUsKriAjDTJaBwwmmha20KOSM3R-52V3ZYwfh0cK3dhqZz4cN619j_Sd-s7Zvf22I0Ilg-AvgRAMHHGLD-veXMfpu3B_N2b-xo3h7Myy87HHmx</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>S-1 plus temozolomide as second-line treatment for neuroendocrine carcinoma of the breast: A case report</title><source>Open Access: PubMed Central</source><creator>Wang, Xin ; Shi, Yan-Fen ; Duan, Jiang-Hui ; Wang, Chao ; Tan, Huang-Ying</creator><creatorcontrib>Wang, Xin ; Shi, Yan-Fen ; Duan, Jiang-Hui ; Wang, Chao ; Tan, Huang-Ying</creatorcontrib><identifier>ISSN: 2307-8960</identifier><identifier>EISSN: 2307-8960</identifier><identifier>DOI: 10.12998/wjcc.v9.i24.7146</identifier><identifier>PMID: 34540971</identifier><language>eng</language><publisher>Baishideng Publishing Group Inc</publisher><subject>Case Report</subject><ispartof>World journal of clinical cases, 2021-08, Vol.9 (24), p.7146-7153</ispartof><rights>The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. 2021</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c343t-66a623e39c70c03231caf1e6174cf25fbe92a1c6c0dd12ce47bce2a2a727f7983</citedby><cites>FETCH-LOGICAL-c343t-66a623e39c70c03231caf1e6174cf25fbe92a1c6c0dd12ce47bce2a2a727f7983</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409205/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409205/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids></links><search><creatorcontrib>Wang, Xin</creatorcontrib><creatorcontrib>Shi, Yan-Fen</creatorcontrib><creatorcontrib>Duan, Jiang-Hui</creatorcontrib><creatorcontrib>Wang, Chao</creatorcontrib><creatorcontrib>Tan, Huang-Ying</creatorcontrib><title>S-1 plus temozolomide as second-line treatment for neuroendocrine carcinoma of the breast: A case report</title><title>World journal of clinical cases</title><subject>Case Report</subject><issn>2307-8960</issn><issn>2307-8960</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNpVkNtKw0AQhhdRbKl9AO_2BRL3kOxmvRBK8QQFL9TrZTOZ2JQkW3bTij69qRXRqxn4__kYPkIuOUu5MKa4et8ApHuTNiJLNc_UCZkKyXRSGMVO_-wTMo9xwxjjnOVcyXMykVmeMaP5lKyfE0637S7SATv_6VvfNRVSF2lE8H2VtE2PdAjohg77gdY-0B53wWNfeQiHEFyApvedo76mwxppObbjcE0XYxSRBtz6MFyQs9q1Eec_c0Ze725flg_J6un-cblYJSAzOSRKOSUkSgOaAZNCcnA1R8V1BrXI6xKNcBwUsKriAjDTJaBwwmmha20KOSM3R-52V3ZYwfh0cK3dhqZz4cN619j_Sd-s7Zvf22I0Ilg-AvgRAMHHGLD-veXMfpu3B_N2b-xo3h7Myy87HHmx</recordid><startdate>20210826</startdate><enddate>20210826</enddate><creator>Wang, Xin</creator><creator>Shi, Yan-Fen</creator><creator>Duan, Jiang-Hui</creator><creator>Wang, Chao</creator><creator>Tan, Huang-Ying</creator><general>Baishideng Publishing Group Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20210826</creationdate><title>S-1 plus temozolomide as second-line treatment for neuroendocrine carcinoma of the breast: A case report</title><author>Wang, Xin ; Shi, Yan-Fen ; Duan, Jiang-Hui ; Wang, Chao ; Tan, Huang-Ying</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c343t-66a623e39c70c03231caf1e6174cf25fbe92a1c6c0dd12ce47bce2a2a727f7983</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Case Report</topic><toplevel>online_resources</toplevel><creatorcontrib>Wang, Xin</creatorcontrib><creatorcontrib>Shi, Yan-Fen</creatorcontrib><creatorcontrib>Duan, Jiang-Hui</creatorcontrib><creatorcontrib>Wang, Chao</creatorcontrib><creatorcontrib>Tan, Huang-Ying</creatorcontrib><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>World journal of clinical cases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Xin</au><au>Shi, Yan-Fen</au><au>Duan, Jiang-Hui</au><au>Wang, Chao</au><au>Tan, Huang-Ying</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>S-1 plus temozolomide as second-line treatment for neuroendocrine carcinoma of the breast: A case report</atitle><jtitle>World journal of clinical cases</jtitle><date>2021-08-26</date><risdate>2021</risdate><volume>9</volume><issue>24</issue><spage>7146</spage><epage>7153</epage><pages>7146-7153</pages><issn>2307-8960</issn><eissn>2307-8960</eissn><pub>Baishideng Publishing Group Inc</pub><pmid>34540971</pmid><doi>10.12998/wjcc.v9.i24.7146</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2307-8960 |
ispartof | World journal of clinical cases, 2021-08, Vol.9 (24), p.7146-7153 |
issn | 2307-8960 2307-8960 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8409205 |
source | Open Access: PubMed Central |
subjects | Case Report |
title | S-1 plus temozolomide as second-line treatment for neuroendocrine carcinoma of the breast: A case report |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T22%3A39%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmedcentral_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=S-1%20plus%20temozolomide%20as%20second-line%20treatment%20for%20neuroendocrine%20carcinoma%20of%20the%20breast:%20A%20case%20report&rft.jtitle=World%20journal%20of%20clinical%20cases&rft.au=Wang,%20Xin&rft.date=2021-08-26&rft.volume=9&rft.issue=24&rft.spage=7146&rft.epage=7153&rft.pages=7146-7153&rft.issn=2307-8960&rft.eissn=2307-8960&rft_id=info:doi/10.12998/wjcc.v9.i24.7146&rft_dat=%3Cpubmedcentral_cross%3Epubmedcentral_primary_oai_pubmedcentral_nih_gov_8409205%3C/pubmedcentral_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c343t-66a623e39c70c03231caf1e6174cf25fbe92a1c6c0dd12ce47bce2a2a727f7983%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/34540971&rfr_iscdi=true |